메뉴 건너뛰기




Volumn 50, Issue 6 SUPPL. A, 1997, Pages 90-96

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: A pooled analysis

Author keywords

[No Author keywords available]

Indexed keywords

OXYBUTYNIN; TOLTERODINE;

EID: 0031471714     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00599-2     Document Type: Conference Paper
Times cited : (298)

References (10)
  • 1
    • 0023906640 scopus 로고
    • Current concepts in the treatment of disorders of micturition
    • Andersson K-E: Current concepts in the treatment of disorders of micturition. Drugs 35: 477-494; 1988.
    • (1988) Drugs , vol.35 , pp. 477-494
    • Andersson, K.-E.1
  • 2
    • 0029265229 scopus 로고
    • Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability
    • Yarker YE, Goa KL, and Fitton A: Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6: 243-262; 1995.
    • (1995) Drugs Aging , vol.6 , pp. 243-262
    • Yarker, Y.E.1    Goa, K.L.2    Fitton, A.3
  • 3
    • 0025866218 scopus 로고
    • Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity
    • Oxybutynin versus propantheline versus placebo
    • Thüroff J, Bunke B, Ebner A, Faber P, de Geeter P, Hannappel J, Heidler H, Madersbacher H, Melchior H, Schäfter W, et al.: Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity. Oxybutynin versus propantheline versus placebo. J Urol 145: 813-817; 1991.
    • (1991) J Urol , vol.145 , pp. 813-817
    • Thüroff, J.1    Bunke, B.2    Ebner, A.3    Faber, P.4    De Geeter, P.5    Hannappel, J.6    Heidler, H.7    Madersbacher, H.8    Melchior, H.9    Schäfter, W.10
  • 4
    • 0023731090 scopus 로고
    • Pharmacokinetics and clinical effects of oxybutynin in geriatric patients
    • Ouslander JG, Blaustein J, Connor A, Orzeck S, and Yong CL: Pharmacokinetics and clinical effects of oxybutynin in geriatric patients. J Urol 140: 47-50; 1988.
    • (1988) J Urol , vol.140 , pp. 47-50
    • Ouslander, J.G.1    Blaustein, J.2    Connor, A.3    Orzeck, S.4    Yong, C.L.5
  • 6
    • 0030903463 scopus 로고    scopus 로고
    • Tolterodine: A new bladder selective, muscarinic receptor antagonist: Preclinical pharmacological and clinical data
    • Nilverbrant L, Hallen B, and Larsson G: Tolterodine: a new bladder selective, muscarinic receptor antagonist: preclinical pharmacological and clinical data. Life Sci 60: 1129-1136; 1997.
    • (1997) Life Sci , vol.60 , pp. 1129-1136
    • Nilverbrant, L.1    Hallen, B.2    Larsson, G.3
  • 7
    • 0024796718 scopus 로고
    • Oxybutynin chloride for geriatric urinary dysfunction: A double-blind placebo-controlled study
    • Zorzitto ML, Holliday PJ, Jewett JA, Herschorn S, and Fernie GR: Oxybutynin chloride for geriatric urinary dysfunction: a double-blind placebo-controlled study. Age Ageing 18: 195-200; 1989.
    • (1989) Age Ageing , vol.18 , pp. 195-200
    • Zorzitto, M.L.1    Holliday, P.J.2    Jewett, J.A.3    Herschorn, S.4    Fernie, G.R.5
  • 8
    • 0022532804 scopus 로고
    • Effectiveness of propantheline bromide in the treatment of geriatric patients with detrusor instability
    • Zorzitto ML, Jewett MAS, Fernie GR, Holliday PJ, and Bartlett S: Effectiveness of propantheline bromide in the treatment of geriatric patients with detrusor instability. Neurourol Urodyn 5: 133-140; 1986.
    • (1986) Neurourol Urodyn , vol.5 , pp. 133-140
    • Zorzitto, M.L.1    Jewett, M.A.S.2    Fernie, G.R.3    Holliday, P.J.4    Bartlett, S.5
  • 9
    • 0028067082 scopus 로고
    • Randomized, double blind trial of terodiline in the treatment of urge incontinence in women
    • Norton P, Karram M, Wall LL, Rosenzweig B, Benson JT, and Fantl JA: Randomized, double blind trial of terodiline in the treatment of urge incontinence in women. Obstet Gynecol 84: 386-391; 1994.
    • (1994) Obstet Gynecol , vol.84 , pp. 386-391
    • Norton, P.1    Karram, M.2    Wall, L.L.3    Rosenzweig, B.4    Benson, J.T.5    Fantl, J.A.6
  • 10
    • 0026877917 scopus 로고
    • The MOS 36-item short-form health survey (SF-36)
    • Conceptual framework and item selection
    • Ware JE, and Sherborune CD: The MOS 36-item short-form health survey (SF-36). Conceptual framework and item selection. Med Care 30: 473-483; 1992.
    • (1992) Med Care , vol.30 , pp. 473-483
    • Ware, J.E.1    Sherborune, C.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.